Serum-derived Bovine Immunoglobulin Effect on Mucositis

Status Terminated

Clinical Trial Summary

The purpose of this cancer control clinical research study is to evaluate whether nutritional therapy with Serum-derived bovine immunoglobulin/protein isolate (SBI) might reduce mucositis (a condition caused by cancer treatment involving mouth sores, pain and/or bleeding that may cause difficulty eating), improve nutritional status and lessen the symptoms associated with chemo-radiation therapy which may result in quality of life (QOL) improvements during the prescribed treatment for cancer therapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Mucositis

Clinical Trial Details

NCT number	NCT04239261
Study type	Interventional
Source	MercyOne Des Moines Medical Center
Contact
Status	Terminated
Phase	Phase 2
Start date	January 17, 2020
Completion date	January 24, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02252926` - Local Anesthetic Treatment of Oral Pain in Patients With Mucositis	Phase 2
Completed	`NCT01155609` - L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer	N/A
Completed	`NCT00357942` - Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy	Phase 4
Completed	`NCT00360685` - Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX	N/A
Completed	`NCT04586491` - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients	N/A
Withdrawn	`NCT02589860` - Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
Not yet recruiting	`NCT02506231` - The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome	Phase 2/Phase 3
Completed	`NCT02605382` - Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis	Phase 2
Completed	`NCT02639377` - Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis	Phase 2
Terminated	`NCT02575313` - The Effects of Whole Food Intervention on Mucositis in Patients Treated for Head and Neck Cancer	Phase 1/Phase 2
Completed	`NCT00956254` - Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis	Phase 3
Completed	`NCT00584597` - A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis	Phase 1
Enrolling by invitation	`NCT05590117` - Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer	Early Phase 1
Completed	`NCT05635929` - Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.	N/A
Completed	`NCT05181943` - Effectiveness of Photo-biomodulation in the Treatment of Chemotherapy Induced Mucositis	N/A
Completed	`NCT03713567` - Clinical, Immunological and Microbiological Evaluation of Experimental Gingivitis and Peri-implant Mucositis	N/A
Completed	`NCT02671812` - Outcome After Dental Implant Treatment
Terminated	`NCT02273752` - Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	Phase 2
Recruiting	`NCT01707641` - Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer	Phase 4
Completed	`NCT01015183` - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate	Phase 2/Phase 3